Zacks Investment Management’s Emergent Biosolutions EBS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11,432	Closed	-$141K	–	737
2025 Q4	$141K	Buy	+11,432	New	+$122K	﹤0.01%	690
2019 Q1	–	Sell	-20,113	Closed	-$1.19M	–	548
2018 Q4	$1.19M	Sell	20,113 -871	-4%	-$56.1K	0.03%	317
2018 Q3	$1.38M	Buy	20,984 +134	+0.6%	+$7.82K	0.03%	343
2018 Q2	$1.05M	Buy	20,850 +417	+2%	+$21.7K	0.02%	416
2018 Q1	$1.08M	Buy	20,433 +1,488	+8%	+$74.2K	0.02%	395
2017 Q4	$880K	Buy	+18,945	New	+$797K	0.02%	428
2016 Q3	–	Sell	-60,441	Closed	-$1.7M	–	669
2016 Q2	$1.7M	Sell	60,441 -43,200	-42%	-$1.69M	0.05%	236
2016 Q1	$3.77M	Buy	103,641 +655	+0.6%	+$23.1K	0.12%	148
2015 Q4	$4.12M	Buy	102,986 +3,470	+3%	+$121K	0.13%	144
2015 Q3	$2.83M	Buy	99,516 +44,861	+82%	+$1.48M	0.1%	162
2015 Q2	$1.8M	Buy	54,655 +192	+0.4%	+$5.95K	0.06%	194
2015 Q1	$1.57M	Buy	54,463 +485	+0.9%	+$13.9K	0.05%	209
2014 Q4	$1.47M	Sell	53,978 -1,946	-3%	-$46.4K	0.05%	207
2014 Q3	$1.19M	Sell	55,924 -5,355	-9%	-$123K	0.04%	221
2014 Q2	$1.38M	Sell	61,279 -18,467	-23%	-$430K	0.05%	205
2014 Q1	$2.02M	Buy	+79,746	New	+$2.01M	0.07%	176